MedPath

PRO-LISDEXAMFETAMINE

PRO-LISDEXAMFETAMINE

Approved
DIN Number

02547031

Drug Class

Human

Market Date

Dec 10, 2024

Company
HC

PRO DOC LIMITEE

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02547031
AIG Number0152536006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA I)
A
ATC Code
N06BA12 LISDEXAMFETAMINE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:20.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

LISDEXAMFETAMINE DIMESYLATEActive
Strength: 10 MG
Monograph: LISDEXAMFETAMINE DIMESYLATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.